Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02997735 · ClinicalTrials.gov registry record · NA

Parent eReferral to Tobacco Quitline

A NA study of Secondhand Smoke, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
484
Enrollment target
1
Study location

NCT02997735 is a NA study of Secondhand Smoke that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 484 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02997735, a NA study of Secondhand Smoke, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
484 participants
Enrollment target
1
Study location

Study Summary

Secondhand smoke (SHS) exposure is a significant public health problem in that it both harms children and is widely prevalent, affecting more than 40% of US children. Tobacco cessation quitlines are effective in helping smokers quit, but few smokers make use of their services. Electronic health record-based systems that automate referral of interested parents to quitlines through pediatric settings may increase the proportion of smokers who successfully enroll in treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Quitline Delivered Treatment

Study Locations (1)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 484 participants
Start Date 2017-01-11
Est. Completion 2018-08
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT02997735

The ClinicalTrials.gov registry entry for NCT02997735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 484 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Secondhand Smoke appearing as the primary indexed condition, and to 1 intervention - of which Quitline Delivered Treatment is the first listed.

NCT02997735 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02997735 about?

NCT02997735 is a clinical study titled "Parent eReferral to Tobacco Quitline". Secondhand smoke (SHS) exposure is a significant public health problem in that it both harms children and is widely prevalent, affecting more than 40% of US children. Tobacco cessation quitlines are effective in helping smokers quit, but few smokers make use of their services. Electronic health reco...

What is the current status of trial NCT02997735?

This trial is currently completed. It is a NA study. The enrollment target is 484 participants. The study started on 2017-01-11. Estimated completion is 2018-08.

What conditions does trial NCT02997735 study?

This clinical trial studies the following conditions: Secondhand Smoke.

What interventions are being tested in trial NCT02997735?

The interventions under investigation include: Quitline Delivered Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02997735?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02997735 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Secondhand Smoke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.